Eszopiclone Patent Expiration
Eszopiclone is used for inducing hypnotic or sedative effects in humans. It was first introduced by Waylis Therapeutics Llc
Eszopiclone Patents
Given below is the list of patents protecting Eszopiclone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lunesta |
US6444673 (Pediatric) | Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing it |
Aug 14, 2014
(Expired) | Waylis Therap |
| Lunesta | US6444673 | Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing it |
Feb 14, 2014
(Expired) | Waylis Therap |
| Lunesta |
US6864257 (Pediatric) | Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing it |
Mar 02, 2013
(Expired) | Waylis Therap |
| Lunesta | US6864257 | Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing it |
Aug 30, 2012
(Expired) | Waylis Therap |
| Lunesta |
US6319926 (Pediatric) | Optically active 5H-pyrrolo[3, 4-B]pyrazine derivative, its preparation and pharmaceutical compositions containing it |
Jul 16, 2012
(Expired) | Waylis Therap |
| Lunesta |
US7381724 (Pediatric) | Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing same |
Jul 16, 2012
(Expired) | Waylis Therap |
Eszopiclone's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List